RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Shorter Clopidogrel Therapy Not Superior following Coronary DES Implantation
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 30
SP 8
OP 9
DO 10.1177/155989771430004
UL http://mdc.sagepub.com/content/14/30/8.abstract
AB In the Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation trial [ISAR-TRIPLE; NCT00776633], 6 weeks of triple therapy including the oral antiplatelet compound clopidogrel is not superior to a 6-month regimen following implantation of a drug-eluting stent.